Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 11/2017

02.07.2017 | Original Article

Bartonella henselae is usually not viable in lymph nodes of patients with cat scratch disease

verfasst von: E. Prudent, H. Lepidi, G. Audoly, B. La Scola, P.-E. Fournier, S. Edouard, E. Angelakis, D. Raoult

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 11/2017

Einloggen, um Zugang zu erhalten

Abstract

Bartonella henselae, the agent of cat scratch disease (CSD), appears to be a common organism responsible for lymphadenitis in both adults and children. There is a very low isolation rate for B. henselae from lymph nodes of patients with CSD. Our objective was to evaluate B. henselae viability in a large series of lymph nodes from patients with CSD. From January to November 2016, we analyzed lymph node biopsy samples from patients diagnosed with CSD. We used reverse transcription-quantitative polymerase chain reaction (RT-qPCR) to detect B. henselae RNA, as well as cultures, histological analyses, and fluorescence in situ hybridization (FISH). We tested 87 lymph nodes positive for B. henselae DNA but only 8 (9%) presented with B. henselae RNA. We did not find a significant difference for the pap threshold cycle (CT) values between RNA-positive and RNA-negative lymph nodes (p = 0.5). Cultures, histological analyses, and FISH were negative for all the tested samples. We provide evidence that B. henselae are not or are rarely viable in most cases in the lymph nodes of patients with CSD.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Amann RI, Krumholz L, Stahl DA (1990) Fluorescent-oligonucleotide probing of whole cells for determinative, phylogenetic, and environmental studies in microbiology. J Bacteriol 172:762–770CrossRefPubMedPubMedCentral Amann RI, Krumholz L, Stahl DA (1990) Fluorescent-oligonucleotide probing of whole cells for determinative, phylogenetic, and environmental studies in microbiology. J Bacteriol 172:762–770CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Angelakis E, Edouard S, La Scola B, Raoult D (2010) Bartonella henselae in skin biopsy specimens of patients with cat-scratch disease. Emerg Infect Dis 16:1963–1965CrossRefPubMedPubMedCentral Angelakis E, Edouard S, La Scola B, Raoult D (2010) Bartonella henselae in skin biopsy specimens of patients with cat-scratch disease. Emerg Infect Dis 16:1963–1965CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Angelakis E, Raoult D (2014) Pathogenicity and treatment of Bartonella infections. Int J Antimicrob Agents 44:16–25CrossRefPubMed Angelakis E, Raoult D (2014) Pathogenicity and treatment of Bartonella infections. Int J Antimicrob Agents 44:16–25CrossRefPubMed
4.
Zurück zum Zitat Angelakis E, Roux V, Raoult D, Rolain J-M (2009) Real-time PCR strategy and detection of bacterial agents of lymphadenitis. Eur J Clin Microbiol Infect Dis 28:1363–1368CrossRefPubMed Angelakis E, Roux V, Raoult D, Rolain J-M (2009) Real-time PCR strategy and detection of bacterial agents of lymphadenitis. Eur J Clin Microbiol Infect Dis 28:1363–1368CrossRefPubMed
6.
Zurück zum Zitat Bass JW, Freitas BC, Freitas AD et al (1998) Prospective randomized double blind placebo-controlled evaluation of azithromycin for treatment of cat-scratch disease. Pediatr Infect Dis J 17:447–452CrossRefPubMed Bass JW, Freitas BC, Freitas AD et al (1998) Prospective randomized double blind placebo-controlled evaluation of azithromycin for treatment of cat-scratch disease. Pediatr Infect Dis J 17:447–452CrossRefPubMed
7.
Zurück zum Zitat Boulouis H-J, Haddad N, Vayssier-Taussat M, Maillard R, Chomel B (2007) Persistent Bartonella infection: epidemiological and clinical implications. Bull Acad Natl Med 191:1037–1044; discussion 1047–1049PubMed Boulouis H-J, Haddad N, Vayssier-Taussat M, Maillard R, Chomel B (2007) Persistent Bartonella infection: epidemiological and clinical implications. Bull Acad Natl Med 191:1037–1044; discussion 1047–1049PubMed
8.
Zurück zum Zitat Breitschwerdt EB, Kordick DL (2000) Bartonella infection in animals: carriership, reservoir potential, pathogenicity, and zoonotic potential for human infection. Clin Microbiol Rev 13:428–438CrossRefPubMedPubMedCentral Breitschwerdt EB, Kordick DL (2000) Bartonella infection in animals: carriership, reservoir potential, pathogenicity, and zoonotic potential for human infection. Clin Microbiol Rev 13:428–438CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Brenner DJ, Hollis DG, Moss CW et al (1991) Proposal of Afipia gen. nov., with Afipia felis sp. nov. (formerly the cat scratch disease bacillus), Afipia clevelandensis sp. nov. (formerly the Cleveland Clinic Foundation strain), Afipia broomeae sp. nov., and three unnamed genospecies. J Clin Microbiol 29:2450–2460PubMedPubMedCentral Brenner DJ, Hollis DG, Moss CW et al (1991) Proposal of Afipia gen. nov., with Afipia felis sp. nov. (formerly the cat scratch disease bacillus), Afipia clevelandensis sp. nov. (formerly the Cleveland Clinic Foundation strain), Afipia broomeae sp. nov., and three unnamed genospecies. J Clin Microbiol 29:2450–2460PubMedPubMedCentral
10.
Zurück zum Zitat Brenner DJ, O’Connor SP, Winkler HH, Steigerwalt AG (1993) Proposals to unify the genera Bartonella and Rochalimaea, with descriptions of Bartonella quintana comb. nov., Bartonella vinsonii comb. nov., Bartonella henselae comb. nov., and Bartonella elizabethae comb. nov., and to remove the family Bartonellaceae from the order Rickettsiales. Int J Syst Bacteriol 43:777–786CrossRefPubMed Brenner DJ, O’Connor SP, Winkler HH, Steigerwalt AG (1993) Proposals to unify the genera Bartonella and Rochalimaea, with descriptions of Bartonella quintana comb. nov., Bartonella vinsonii comb. nov., Bartonella henselae comb. nov., and Bartonella elizabethae comb. nov., and to remove the family Bartonellaceae from the order Rickettsiales. Int J Syst Bacteriol 43:777–786CrossRefPubMed
11.
Zurück zum Zitat Brock TD (1999) Robert Koch: a life in medicine and bacteriology. ASM Press, Washington, DCCrossRef Brock TD (1999) Robert Koch: a life in medicine and bacteriology. ASM Press, Washington, DCCrossRef
12.
Zurück zum Zitat Cenciarini C, Courtois S, Raoult D, La Scola B (2008) Influence of long time storage in mineral water on RNA stability of Pseudomonas aeruginosa and Escherichia coli after heat inactivation. PLoS One 3:e3443CrossRefPubMedPubMedCentral Cenciarini C, Courtois S, Raoult D, La Scola B (2008) Influence of long time storage in mineral water on RNA stability of Pseudomonas aeruginosa and Escherichia coli after heat inactivation. PLoS One 3:e3443CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Debré R, Job J-C (1954) Cat scratch fever. Acta Paediatr 43:386–389CrossRef Debré R, Job J-C (1954) Cat scratch fever. Acta Paediatr 43:386–389CrossRef
14.
Zurück zum Zitat Edouard S, Million M, Lepidi H et al (2013) Persistence of DNA in a cured patient and positive culture in cases with low antibody levels bring into question diagnosis of Q fever endocarditis. J Clin Microbiol 51:3012–3017CrossRefPubMedPubMedCentral Edouard S, Million M, Lepidi H et al (2013) Persistence of DNA in a cured patient and positive culture in cases with low antibody levels bring into question diagnosis of Q fever endocarditis. J Clin Microbiol 51:3012–3017CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Edouard S, Raoult D (2010) Bartonella henselae, un agent d’infections ubiquitaires. Med Mal Infect 40:319–330CrossRefPubMed Edouard S, Raoult D (2010) Bartonella henselae, un agent d’infections ubiquitaires. Med Mal Infect 40:319–330CrossRefPubMed
16.
Zurück zum Zitat Eldin C, Angelakis E, Renvoisé A, Raoult D (2013) Coxiella burnetii DNA, but not viable bacteria, in dairy products in France. Am J Trop Med Hyg 88:765–769CrossRefPubMedPubMedCentral Eldin C, Angelakis E, Renvoisé A, Raoult D (2013) Coxiella burnetii DNA, but not viable bacteria, in dairy products in France. Am J Trop Med Hyg 88:765–769CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat English CK, Wear DJ, Margileth AM, Lissner CR, Walsh GP (1988) Cat-scratch disease. Isolation and culture of the bacterial agent. JAMA 259:1347–1352CrossRefPubMed English CK, Wear DJ, Margileth AM, Lissner CR, Walsh GP (1988) Cat-scratch disease. Isolation and culture of the bacterial agent. JAMA 259:1347–1352CrossRefPubMed
18.
Zurück zum Zitat Gouriet F, Fenollar F, Patrice J-Y, Drancourt M, Raoult D (2005) Use of shell-vial cell culture assay for isolation of bacteria from clinical specimens: 13 years of experience. J Clin Microbiol 43:4993–5002CrossRefPubMedPubMedCentral Gouriet F, Fenollar F, Patrice J-Y, Drancourt M, Raoult D (2005) Use of shell-vial cell culture assay for isolation of bacteria from clinical specimens: 13 years of experience. J Clin Microbiol 43:4993–5002CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Gouriet F, Lepidi H, Habib G, Collart F, Raoult D (2007) From cat scratch disease to endocarditis, the possible natural history of Bartonella henselae infection. BMC Infect Dis 7:30CrossRefPubMedPubMedCentral Gouriet F, Lepidi H, Habib G, Collart F, Raoult D (2007) From cat scratch disease to endocarditis, the possible natural history of Bartonella henselae infection. BMC Infect Dis 7:30CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Gradidge E, Chauhan A, Steele RW, Warrier R (2013) Fever, lymphadenopathy, and splenomegaly: did the cat do it? Clin Pediatr (Phila) 52:1072–1074CrossRef Gradidge E, Chauhan A, Steele RW, Warrier R (2013) Fever, lymphadenopathy, and splenomegaly: did the cat do it? Clin Pediatr (Phila) 52:1072–1074CrossRef
21.
Zurück zum Zitat Jabcuga CE, Jin L, Macon WR, Howard MT, Oliveira AM, King RL (2016) Broadening the morphologic spectrum of Bartonella henselae lymphadenitis: analysis of 100 molecularly characterized cases. Am J Surg Pathol 40:342–347CrossRefPubMed Jabcuga CE, Jin L, Macon WR, Howard MT, Oliveira AM, King RL (2016) Broadening the morphologic spectrum of Bartonella henselae lymphadenitis: analysis of 100 molecularly characterized cases. Am J Surg Pathol 40:342–347CrossRefPubMed
22.
Zurück zum Zitat Kempf VAJ, Schaller M, Behrendt S et al (2000) Interaction of Bartonella henselae with endothelial cells results in rapid bacterial rRNA synthesis and replication. Cell Microbiol 2:431–441CrossRefPubMed Kempf VAJ, Schaller M, Behrendt S et al (2000) Interaction of Bartonella henselae with endothelial cells results in rapid bacterial rRNA synthesis and replication. Cell Microbiol 2:431–441CrossRefPubMed
23.
Zurück zum Zitat Kunz S, Oberle K, Sander A, Bogdan C, Schleicher U (2008) Lymphadenopathy in a novel mouse model of Bartonella-induced cat scratch disease results from lymphocyte immigration and proliferation and is regulated by interferon-α/β. Am J Pathol 172:1005–1018CrossRefPubMedPubMedCentral Kunz S, Oberle K, Sander A, Bogdan C, Schleicher U (2008) Lymphadenopathy in a novel mouse model of Bartonella-induced cat scratch disease results from lymphocyte immigration and proliferation and is regulated by interferon-α/β. Am J Pathol 172:1005–1018CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat La Scola B, Raoult D (1999) Afipia felis in hospital water supply in association with free-living amoebae. Lancet 353:1330CrossRefPubMed La Scola B, Raoult D (1999) Afipia felis in hospital water supply in association with free-living amoebae. Lancet 353:1330CrossRefPubMed
25.
Zurück zum Zitat La Scola B, Raoult D (1999) Culture of Bartonella quintana and Bartonella henselae from human samples: a 5-year experience (1993 to 1998). J Clin Microbiol 37:1899–1905PubMedPubMedCentral La Scola B, Raoult D (1999) Culture of Bartonella quintana and Bartonella henselae from human samples: a 5-year experience (1993 to 1998). J Clin Microbiol 37:1899–1905PubMedPubMedCentral
26.
Zurück zum Zitat Leone M, Honstettre A, Lepidi H et al (2004) Effect of sex on Coxiella burnetii infection: protective role of 17β-estradiol. J Infect Dis 189:339–345CrossRefPubMed Leone M, Honstettre A, Lepidi H et al (2004) Effect of sex on Coxiella burnetii infection: protective role of 17β-estradiol. J Infect Dis 189:339–345CrossRefPubMed
27.
Zurück zum Zitat Lepidi H, Fournier P-E, Raoult D (2000) Quantitative analysis of Valvular lesions during Bartonella endocarditis. Am J Clin Pathol 114:880–889CrossRefPubMed Lepidi H, Fournier P-E, Raoult D (2000) Quantitative analysis of Valvular lesions during Bartonella endocarditis. Am J Clin Pathol 114:880–889CrossRefPubMed
28.
Zurück zum Zitat Mallmann C, Siemoneit S, Schmiedel D et al (2010) Fluorescence in situ hybridization to improve the diagnosis of endocarditis: a pilot study. Clin Microbiol Infect 16:767–773CrossRefPubMed Mallmann C, Siemoneit S, Schmiedel D et al (2010) Fluorescence in situ hybridization to improve the diagnosis of endocarditis: a pilot study. Clin Microbiol Infect 16:767–773CrossRefPubMed
29.
Zurück zum Zitat Margileth AM (1992) Antibiotic therapy for cat-scratch disease: clinical study of therapeutic outcome in 268 patients and a review of the literature. Pediatr Infect Dis J 11:474–478CrossRefPubMed Margileth AM (1992) Antibiotic therapy for cat-scratch disease: clinical study of therapeutic outcome in 268 patients and a review of the literature. Pediatr Infect Dis J 11:474–478CrossRefPubMed
30.
Zurück zum Zitat Margileth AW, Wear DJ, Hadfield TL, Schlagel CJ, Spigel GT, Muhlbauer JE (1984) Cat-scratch disease. Bacteria in skin at the primary inoculation site. JAMA 252:928–931CrossRefPubMed Margileth AW, Wear DJ, Hadfield TL, Schlagel CJ, Spigel GT, Muhlbauer JE (1984) Cat-scratch disease. Bacteria in skin at the primary inoculation site. JAMA 252:928–931CrossRefPubMed
31.
Zurück zum Zitat Morel A-S, Dubourg G, Prudent E et al (2015) Complementarity between targeted real-time specific PCR and conventional broad-range 16S rDNA PCR in the syndrome-driven diagnosis of infectious diseases. Eur J Clin Microbiol Infect Dis 34:561–570CrossRefPubMed Morel A-S, Dubourg G, Prudent E et al (2015) Complementarity between targeted real-time specific PCR and conventional broad-range 16S rDNA PCR in the syndrome-driven diagnosis of infectious diseases. Eur J Clin Microbiol Infect Dis 34:561–570CrossRefPubMed
32.
Zurück zum Zitat Prutsky G, Domecq JP, Mori L et al (2013) Treatment outcomes of human bartonellosis: a systematic review and meta-analysis. Int J Infect Dis 17:e811–e819CrossRefPubMed Prutsky G, Domecq JP, Mori L et al (2013) Treatment outcomes of human bartonellosis: a systematic review and meta-analysis. Int J Infect Dis 17:e811–e819CrossRefPubMed
33.
Zurück zum Zitat Regnery R, Martin M, Olson J (1992) Naturally occurring “Rochalimaea henselae” infection in domestic cat. Lancet 340:557–558CrossRefPubMed Regnery R, Martin M, Olson J (1992) Naturally occurring “Rochalimaea henselae” infection in domestic cat. Lancet 340:557–558CrossRefPubMed
34.
Zurück zum Zitat Regnery RL, Olson JG, Perkins BA, Bibb W (1992) Serological response to “Rochalimaea henselae” antigen in suspected cat-scratch disease. Lancet 339:1443–1445CrossRefPubMed Regnery RL, Olson JG, Perkins BA, Bibb W (1992) Serological response to “Rochalimaea henselae” antigen in suspected cat-scratch disease. Lancet 339:1443–1445CrossRefPubMed
35.
Zurück zum Zitat Resto-Ruiz S, Burgess A, Anderson BE (2003) The role of the host immune response in pathogenesis of Bartonella henselae. DNA Cell Biol 22:431–440CrossRefPubMed Resto-Ruiz S, Burgess A, Anderson BE (2003) The role of the host immune response in pathogenesis of Bartonella henselae. DNA Cell Biol 22:431–440CrossRefPubMed
36.
Zurück zum Zitat Ridder GJ, Boedeker CC, Technau-Ihling K, Grunow R, Sander A (2002) Role of cat-scratch disease in lymphadenopathy in the head and neck. Clin Infect Dis 35:643–649CrossRefPubMed Ridder GJ, Boedeker CC, Technau-Ihling K, Grunow R, Sander A (2002) Role of cat-scratch disease in lymphadenopathy in the head and neck. Clin Infect Dis 35:643–649CrossRefPubMed
37.
Zurück zum Zitat Rolain JM, Brouqui P, Koehler JE, Maguina C, Dolan MJ, Raoult D (2004) Recommendations for treatment of human infections caused by Bartonella species. Antimicrob Agents Chemother 48:1921–1933CrossRefPubMedPubMedCentral Rolain JM, Brouqui P, Koehler JE, Maguina C, Dolan MJ, Raoult D (2004) Recommendations for treatment of human infections caused by Bartonella species. Antimicrob Agents Chemother 48:1921–1933CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Rolain JM, Gouriet F, Enea M, Aboud M, Raoult D (2003) Detection by immunofluorescence assay of Bartonella henselae in lymph nodes from patients with cat scratch disease. Clin Diagn Lab Immunol 10:686–691PubMedPubMedCentral Rolain JM, Gouriet F, Enea M, Aboud M, Raoult D (2003) Detection by immunofluorescence assay of Bartonella henselae in lymph nodes from patients with cat scratch disease. Clin Diagn Lab Immunol 10:686–691PubMedPubMedCentral
39.
40.
Zurück zum Zitat Rovery C, Greub G, Lepidi H et al (2005) PCR detection of bacteria on cardiac valves of patients with treated bacterial endocarditis. J Clin Microbiol 43:163–167CrossRefPubMedPubMedCentral Rovery C, Greub G, Lepidi H et al (2005) PCR detection of bacteria on cardiac valves of patients with treated bacterial endocarditis. J Clin Microbiol 43:163–167CrossRefPubMedPubMedCentral
41.
Zurück zum Zitat Safont M, Angelakis E, Richet H et al (2014) Bacterial lymphadenitis at a major referral hospital in France from 2008 to 2012. J Clin Microbiol 52:1161–1167CrossRefPubMedPubMedCentral Safont M, Angelakis E, Richet H et al (2014) Bacterial lymphadenitis at a major referral hospital in France from 2008 to 2012. J Clin Microbiol 52:1161–1167CrossRefPubMedPubMedCentral
42.
Zurück zum Zitat Shinall EA (1990) Cat-scratch disease: a review of the literature. Pediatr Dermatol 7:11–18CrossRefPubMed Shinall EA (1990) Cat-scratch disease: a review of the literature. Pediatr Dermatol 7:11–18CrossRefPubMed
43.
Zurück zum Zitat Sung K, Hiett KL, Stern NJ (2005) Heat-treated Campylobacter spp. and mRNA stability as determined by reverse transcriptase-polymerase chain reaction. Foodborne Pathog Dis 2:130–137CrossRefPubMed Sung K, Hiett KL, Stern NJ (2005) Heat-treated Campylobacter spp. and mRNA stability as determined by reverse transcriptase-polymerase chain reaction. Foodborne Pathog Dis 2:130–137CrossRefPubMed
44.
Zurück zum Zitat Vayssier-Taussat M, Moutailler S, Féménia F et al (2016) Identification of novel zoonotic activity of Bartonella spp., France. Emerg Infect Dis 22:457–462CrossRefPubMedPubMedCentral Vayssier-Taussat M, Moutailler S, Féménia F et al (2016) Identification of novel zoonotic activity of Bartonella spp., France. Emerg Infect Dis 22:457–462CrossRefPubMedPubMedCentral
45.
Zurück zum Zitat Vermi W, Facchetti F, Riboldi E et al (2006) Role of dendritic cell-derived CXCL13 in the pathogenesis of Bartonella henselae B-rich granuloma. Blood 107:454–462CrossRefPubMed Vermi W, Facchetti F, Riboldi E et al (2006) Role of dendritic cell-derived CXCL13 in the pathogenesis of Bartonella henselae B-rich granuloma. Blood 107:454–462CrossRefPubMed
46.
Zurück zum Zitat Wallner G, Amann R, Beisker W (1993) Optimizing fluorescent in situ hybridization with rRNA-targeted oligonucleotide probes for flow cytometric identification of microorganisms. Cytometry 14:136–143CrossRefPubMed Wallner G, Amann R, Beisker W (1993) Optimizing fluorescent in situ hybridization with rRNA-targeted oligonucleotide probes for flow cytometric identification of microorganisms. Cytometry 14:136–143CrossRefPubMed
47.
Zurück zum Zitat Wear DJ, Margileth AM, Hadfield TL, Fischer GW, Schlagel CJ, King FM (1983) Cat scratch disease: a bacterial infection. Science 221:1403–1405CrossRefPubMed Wear DJ, Margileth AM, Hadfield TL, Fischer GW, Schlagel CJ, King FM (1983) Cat scratch disease: a bacterial infection. Science 221:1403–1405CrossRefPubMed
48.
Zurück zum Zitat Yaron S, Matthews KR (2002) A reverse transcriptase-polymerase chain reaction assay for detection of viable Escherichia coli O157:H7: investigation of specific target genes. J Appl Microbiol 92:633–640CrossRefPubMed Yaron S, Matthews KR (2002) A reverse transcriptase-polymerase chain reaction assay for detection of viable Escherichia coli O157:H7: investigation of specific target genes. J Appl Microbiol 92:633–640CrossRefPubMed
Metadaten
Titel
Bartonella henselae is usually not viable in lymph nodes of patients with cat scratch disease
verfasst von
E. Prudent
H. Lepidi
G. Audoly
B. La Scola
P.-E. Fournier
S. Edouard
E. Angelakis
D. Raoult
Publikationsdatum
02.07.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 11/2017
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-017-3047-z

Weitere Artikel der Ausgabe 11/2017

European Journal of Clinical Microbiology & Infectious Diseases 11/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.